Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2026-01-02 @ 12:57 PM
Study NCT ID:
NCT02843061
Status:
COMPLETED
Last Update Posted:
2019-09-12
First Post:
2016-07-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Rituximab and NK Immunotherapy for B Lymphoma
Sponsor:
Fuda Cancer Hospital, Guangzhou
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NK-Rituximab
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |